These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11057343)

  • 21. [Pharmacological profile and clinical efficacy of olopatadine hydrochloride ophthalmic solution (Patanol 0.1% ophthalmic solution)].
    Watanabe M; Kodama H; Hasegawa K; Itoh K
    Nihon Yakurigaku Zasshi; 2007 Sep; 130(3):221-31. PubMed ID: 17878619
    [No Abstract]   [Full Text] [Related]  

  • 22. Use of olopatadine ophthalmic solution and reactivity of histamine skin testing.
    Jones JD; Temino VM; Dworski R; Anderson CK; Fahrenholz JM; An AQ
    Allergy Asthma Proc; 2008; 29(6):636-9. PubMed ID: 19173791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative study of clinical efficacy and tolerance in seasonal allergic conjunctivitis management with 0.1% olopatadine hydrochloride versus 0.05% ketotifen fumarate.
    Aguilar AJ
    Acta Ophthalmol Scand Suppl; 2000; (230):52-5. PubMed ID: 11057352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the efficacy of combined fluticasone propionate and olopatadine versus combined fluticasone propionate and fexofenadine for the treatment of allergic rhinoconjunctivitis induced by conjunctival allergen challenge.
    Lanier BQ; Abelson MB; Berger WE; Granet DB; D'Arienzo PA; Spangler DL; Kägi MK
    Clin Ther; 2002 Jul; 24(7):1161-74. PubMed ID: 12182260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized, double-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the conjunctival and nasal allergen challenge models.
    Spangler DL; Abelson MB; Ober A; Gotnes PJ
    Clin Ther; 2003 Aug; 25(8):2245-67. PubMed ID: 14512132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of the ocular antiallergic and antihistaminic effects of olopatadine (AL-4943A), a novel drug for treating ocular allergic diseases.
    Sharif NA; Xu SX; Miller ST; Gamache DA; Yanni JM
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1252-61. PubMed ID: 8819509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A review of the use of olopatadine in allergic conjunctivitis.
    McGill JI
    Int Ophthalmol; 2004 May; 25(3):171-9. PubMed ID: 15847317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the efficacy of olopatadine hydrochloride 0.1% ophthalmic solution and azelastine hydrochloride 0.05% ophthalmic solution in the conjunctival allergen challenge model.
    Spangler DL; Bensch G; Berdy GJ
    Clin Ther; 2001 Aug; 23(8):1272-80. PubMed ID: 11558863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitory effect of olopatadine on antigen-induced eosinophil infiltration and the LFA-1 and Mac-1 expression in eosinophils.
    Fukuishi N; Matsuhisa M; Shimono T; Murata N; Iwanaga M; Sagara H; Matsui N; Akagi M
    Jpn J Pharmacol; 2002 Apr; 88(4):463-6. PubMed ID: 12046991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of olopatadine hydrochloride on the cutaneous vascular hyperpermeability and the scratching behavior induced by poly-L-arginine in rats.
    Hayashi K; Kaise T; Ohmori K; Ishii A; Karasawa A
    Jpn J Pharmacol; 2001 Oct; 87(2):167-70. PubMed ID: 11700017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of olopatadine and other histamine H1 receptor antagonists on the skin inflammation induced by repeated topical application of oxazolone in mice.
    Tamura T; Masaki S; Ohmori K; Karasawa A
    Pharmacology; 2005 Dec; 75(1):45-52. PubMed ID: 15942272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Olopatadine for allergic conjunctivitis.
    Med Lett Drugs Ther; 1997 Nov; 39(1014):108-9. PubMed ID: 9398823
    [No Abstract]   [Full Text] [Related]  

  • 33. Brain histamine H receptor occupancy of orally administered antihistamines measured by positron emission tomography with (11)C-doxepin in a placebo-controlled crossover study design in healthy subjects: a comparison of olopatadine and ketotifen.
    Tashiro M; Mochizuki H; Sakurada Y; Ishii K; Oda K; Kimura Y; Sasaki T; Ishiwata K; Yanai K
    Br J Clin Pharmacol; 2006 Jan; 61(1):16-26. PubMed ID: 16390347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of oral olopatadine hydrochloride for the treatment of seasonal allergic rhinitis: A randomized, double-blind, placebo-controlled study.
    Yamamoto H; Yamada T; Kubo S; Osawa Y; Kimura Y; Oh M; Susuki D; Takabayashi T; Okamoto M; Fujieda S
    Allergy Asthma Proc; 2010; 31(4):296-303. PubMed ID: 20819319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of olopatadine hydrochloride on the increase of histamine and peptide-leukotrienes concentrations in nasal lavage fluid following the antigen-antibody reaction in actively sensitized guinea pigs.
    Miyake K; Horikoshi K; Ikeda Y; Ishii A; Karasawa A
    Jpn J Pharmacol; 2001 Apr; 85(4):453-6. PubMed ID: 11388650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adsorption of levocabastine eye drops by soft contact lenses and its effects in rabbit eyes.
    Momose T; Ito N; Kanai A; Watanabe Y; Shibata M
    CLAO J; 1997 Apr; 23(2):96-9. PubMed ID: 9108973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical efficacy of olopatadine vs epinastine ophthalmic solution in the conjunctival allergen challenge model.
    Lanier BQ; Finegold I; D'Arienzo P; Granet D; Epstein AB; Ledgerwood GL
    Curr Med Res Opin; 2004 Aug; 20(8):1227-33. PubMed ID: 15324525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Olopatadine hydrochloride ophthalmic solution for the treatment of allergic conjunctivitis.
    Gonzalez-Estrada A; Reddy K; Dimov V; Eidelman F
    Expert Opin Pharmacother; 2017 Aug; 18(11):1137-1143. PubMed ID: 28656804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the clinical efficacy and comfort of olopatadine hydrochloride 0.1% ophthalmic solution and nedocromil sodium 2% ophthalmic solution in the human conjunctival allergen challenge model.
    Butrus S; Greiner JV; Discepola M; Finegold I
    Clin Ther; 2000 Dec; 22(12):1462-72. PubMed ID: 11192137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Double-blind, crossover comparison of olopatadine and cetirizine versus placebo: suppressive effects on skin response to histamine iontophoresis.
    Morita E; Matsuo H; Zhang Y
    J Dermatol; 2005 Jan; 32(1):58-61. PubMed ID: 15841664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.